ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 182,02
0,62%
Dow Jones
39 212,82
0,40%
DAX
18 681,48
1,05%
Brent Oil
83,82
0,31%
Bitcoin
61 214,29
0,04%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Impax Laboratories, Inc. (delisted) (IPXL)

  7. Impax Laboratories, Inc. (delisted) (IPXL) Actualités

IPXL

Impax Laboratories, Inc. (delisted) (IPXL)

Impax Laboratories, Inc. (delisted)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IPXL
DateHeureSourceTitreSymboleSociété
14/02/201922h00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
12/02/201915h47Edgar (US Regulatory)Schedule 13gNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
07/06/201822h35Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
10/05/201822h20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
08/05/201822h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
07/05/201815h11Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
07/05/201814h30PR Newswire (US)ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/ImpaxNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
07/05/201814h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
07/05/201812h00PR Newswire (US)Amneal and Impax Complete Business CombinationNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
04/05/201823h05Edgar (US Regulatory)(25-NSE)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
03/05/201800h19PR Newswire (US)Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
28/04/201800h50PR Newswire (US)Amneal And Impax Receive FTC Clearance For Business CombinationNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
28/04/201800h30PR Newswire (US)ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/ImpaxNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
13/04/201823h04Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
06/04/201813h33PR Newswire (US)Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
05/04/201823h24Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
27/03/201822h05PR Newswire (US)Impax Shareholders Approve Proposed Business Combination with AmnealNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
20/03/201811h04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
14/03/201813h00PR Newswire (US)Amneal Gains Approval for Erythromycin Tablets USPNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
07/03/201814h35PR Newswire (US)Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare ConferenceNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
01/03/201823h05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
01/03/201813h30PR Newswire (US)Amneal Launches Generic for Tamiflu® Oral SuspensionNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
01/03/201813h00PR Newswire (US)Impax Reports Fourth Quarter and Full Year 2017 ResultsNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
21/02/201813h51PR Newswire (US)Amneal Introduces Memantine Hydrochloride Extended-Release Capsules, Generic for Namenda XR®NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
20/02/201822h05PR Newswire (US)Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release TabletsNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
12/02/201822h49Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
12/02/201819h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
06/02/201813h30PR Newswire (US)Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial OperationsNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
05/02/201813h00PR Newswire (US)Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta®NASDAQ:IPXLImpax Laboratories, Inc. (delisted)
01/02/201814h55PR Newswire (US)Amneal Introduces Isotretinoin Capsules, USPNASDAQ:IPXLImpax Laboratories, Inc. (delisted)
 Showing the most relevant articles for your search:NASDAQ:IPXL

Dernières Valeurs Consultées

NYSE
MRK
Merck
EU
VIV
Vivendi
COIN
ETHUSD
Ethereum
EU
VK
Vallourec
FTSE
UKX
FTSE 100
NASDAQ
AAPL
Apple
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
EU
DG
Vinci
EU
BNP
BNP Paribas
EU
AI
Air Liquide
EU
RI
Pernod Ricard
EU
RNO
Renault
EU
SGO
Cie de SaintGobain
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés